Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: Acceptable toxicity and suggestion of improved 1-year disease-free survival

International Journal of Radiation Oncology Biology Physics

Volumn 48, Issue 4, 2000, Pages 1089-1096

  Chakravarthy, Anuradha ^a   Abrams, Ross A ^a,b   Yeo, Charles J ^a   Korman, Larry T ^a   Donehower, Ross C ^a   Hruban, Ralph H ^a   Zahurek, Marianna L ^a   Grochow, Louise B ^a   O'Reilly, Seamus ^a   Hurwitz, Herbert ^a   Jaffee, Elizabeth M ^a   Lillemoe, Keith D ^a   Cameron, John L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Nonpancreatic periampullary; Pancreatic; Pancreaticoduodenectomy

Indexed keywords

DIPYRIDAMOLE; FLUOROURACIL; FOLINIC ACID; MITOMYCIN C;

ADENOCARCINOMA; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BEAM THERAPY; BILE DUCT CANCER; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; DUODENUM CANCER; DYSPNEA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC DISEASE; HISTOLOGY; HUMAN; LIVER CANCER; LIVER TOXICITY; LUNG TOXICITY; LYMPH NODE METASTASIS; MALE; MULTIMODALITY CANCER THERAPY; PANCREAS CANCER; PANCREATICODUODENECTOMY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RECURRENCE RISK; SURVIVAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; DIPYRIDAMOLE; DISEASE-FREE SURVIVAL; DUODENAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; TIME FACTORS;

EID: 0034333248     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00755-0     Document Type: Article

References (34)

1. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s; Pathology, complications, and outcomes
2. Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head
3. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection
4. Pancreaticoduodenectomy for pancreatic adenocarcinoma:postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience
5. Periampullaly adenocarcinoma analysis of 5-year survivors
6. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma survival results and observations regarding; Patterns of failure, radiotherapy dose, and CA 19-9 levels
7. Continuous infusion (CI) 5-fluorouracil (5FU), calcium leucovorin (LV), mitomycin-C (mito C), and dipyridamole (D) treatment for patients with locally advanced pancreatic cancer
8. Pancreaticodoudenectomy with or without extended retroperitonel lymphadenoectomy for periampullary adenocarcinoma
9. Nonparametric estimation from incomplete observations
10. Statistical aspects of the analysis of data from retrospective studies of disease
11. Regression models and life tables
12. Split course radiation therapy for adenocarcinoma of the pancreas
13. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer
14. Chemotherapy of adenocarcinoma of the prostate
15. Radiation therapy and 5-fluorouracil modulated by leucovorin for adenocarcinoma of the pancreas. A phase I study
16. Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma
17. Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas; Results of a phase II trial
18. Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy
19. A study of various strategies to enhance the cytotoxic activity of 5-fluorouracil/leucovorin in human colorectal cancer cell lines
20. Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer; a prospective randomized trial
21. Biochemical modulation of fluorouracil by dipyridamole; Preclinical and clinical experience
22. The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitization
23. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum
24. Mitomycin-C, and cisplatin increase survival in a human pancreatic cancer metastatic model
25. Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A southwest oncology group study
26. 5-fluorouracil, Adriamycin, mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas
27. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region. Phase III Trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group
28. Adjuvant therapy for pancreatic cancer; Back to the future
29. Gem vs. 5-FU (Abstr.)
30. Gemcitabine and radiosensitization in human tumor cells
31. A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma